Literature DB >> 8840447

Complications in laparoscopic and open cholecystectomy: a prospective comparative trial.

T Buanes1, O Mjåland.   

Abstract

Laparoscopic cholecystectomy (n = 250) was compared with the open procedure (n = 250) in a prospective comparative study focusing on complications. Severity grade was classified according to the Toronto system. The frequency of severity grade 1 complications was equal after open and laparoscopic cholecystectomy (5.6%), but major complications (grade 2 and higher) were significantly more frequent in the open group (10.4 versus 3.6%). The only postoperative death occurred after open cholecystectomy. The conventional advantages of laparoscopic cholecystectomy were also verified: The need for postoperative analgesics was significantly reduced from 7 (range, 4-16) standard opiate doses in the open group to 3 (range, 0-7) in the laparoscopic group. Hospital stay was reduced from 6 (range, 4-31) days after open surgery to 2 (range, 1-7) days after laparoscopic surgery and sick leave from 28 (range, 18-48) to 10 (range, 2-21) days, respectively. The overall complication rate was significantly higher in the open group (16 versus 9%, p < 0.01). In our hands, laparoscopic cholecystectomy carries a lower risk of serious complications than the open procedure.

Entities:  

Mesh:

Year:  1996        PMID: 8840447

Source DB:  PubMed          Journal:  Surg Laparosc Endosc        ISSN: 1051-7200


  19 in total

1.  The impact of body mass index on outcomes after laparoscopic cholecystectomy.

Authors:  Daniel T Farkas; Dovid Moradi; David Moaddel; Kamal Nagpal; John Morgan Cosgrove
Journal:  Surg Endosc       Date:  2011-10-20       Impact factor: 4.584

Review 2.  Biliary complications secondary to post-cholecystectomy clip migration: a review of 69 cases.

Authors:  Vui Heng Chong; Chee Fui Chong
Journal:  J Gastrointest Surg       Date:  2010-01-05       Impact factor: 3.452

3.  Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.

Authors:  P R Schauer; S Ikramuddin; W Gourash; R Ramanathan; J Luketich
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

4.  Treatment of gallstone and gallbladder disease using cholecystectomy. The Society for Surgery of the Alimentary Tract Patient Care Committee.

Authors: 
Journal:  J Gastrointest Surg       Date:  1998 Sep-Oct       Impact factor: 3.452

5.  Carbon dioxide pneumoperitoneum prevents mortality from sepsis.

Authors:  E J Hanly; J M Fuentes; A R Aurora; S L Bachman; A De Maio; M R Marohn; M A Talamini
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

6.  CO2 Pneumoperitoneum modifies the inflammatory response to sepsis.

Authors:  Eric J Hanly; Mario Mendoza-Sagaon; Kazanuri Murata; Jeffrey M Hardacre; Antonio De Maio; Mark A Talamini
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

7.  Transumbilical approach for shunt insertion in the pediatric population: an improvement in cosmetic results.

Authors:  Didier Scavarda; J Breaud; M Khalil; A Paz Paredes; M Takahashi; V Fouquet; C Louis-Borrione; G Lena
Journal:  Childs Nerv Syst       Date:  2004-10-01       Impact factor: 1.475

8.  Small-incision (mini-laparotomy) versus laparoscopic cholecystectomy: a retrospective study in a university hospital.

Authors:  Theodoros Syrakos; Polichronis Antonitsis; Emmanouil Zacharakis; Athanasios Takis; Antonia Manousari; Konstantinos Bakogiannis; George Efthimiopoulos; Ignatios Achoulias; Anastasia Trikoupi; Dimitrios Kiskinis
Journal:  Langenbecks Arch Surg       Date:  2004-05-07       Impact factor: 3.445

9.  Outcome of laparoscopic cholecystectomy is not influenced by chronological age in the elderly.

Authors:  Hyung-Ook Kim; Jung-Won Yun; Jun-Ho Shin; Sang-Il Hwang; Yong-Kyun Cho; Byung-Ho Son; Chang-Hak Yoo; Yong-Lai Park; Hungdai Kim
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

10.  Current trends in laparoscopic cholecystectomy.

Authors:  A A Al-Mulhim
Journal:  J Family Community Med       Date:  1997-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.